Skip to content
Wednesday, May 6, 2026
  • Headlines
  • Business
  • Economy
  • Politics
  • Top News
  • Newsletters
The Cheap Investor

The Cheap Investor

  • Headlines
  • Business
  • Economy
  • Politics
  • Top News
  • Newsletters
The Cheap Investor

The Cheap Investor

  • Headlines
  • Business
  • Economy
  • Politics
  • Top News
  • Newsletters
  • Home
  • 2023
  • July
  • 7
  • US FDA grants standard approval of Eisai/Biogen Alzheimer’s drug
  • FILE PHOTO: Handout image shows Alzheimer’s drug LEQEMBI

    FILE PHOTO: Handout image shows Alzheimer’s drug LEQEMBI

    FILE PHOTO: The Alzheimer’s drug LEQEMBI is seen in this undated handout image obtained by Reuters on January 20, 2023. Eisai/Handout via REUTERS/File Photo

    Post navigation

    Previous: US FDA grants standard approval of Eisai/Biogen Alzheimer’s drug

    Live Market Pulse

    The charting technology is provided by TradingView. Learn how to use theTradingView Stock Screener.

    Sign up for our free The Cheap Investor Newsletter!

    Discover new market trends and ideas directly to your inbox.

    ✅ You're in! Check your inbox soon.

    By submitting your email address, you'll receive a free subscription to The Cheap Investor newsletter (Privacy Policy). These newsletters are completely free - and always will be. You will also receive occasional offers about products and services available to you from our affiliates. You can unsubscribe at any time.

    Recent Posts

    • In by 9:35 AM. Out by 10.
    • VSEC: The Aviation MRO Play Under the Radar
    • Stellantis Is Down Big From Its Peak. Is it a Bargain?
    • The ONE Ticker to Own Before May 15
    • The Humanoid Trade Is No Longer a 2030 Story
    • Monday Morning Movers: What Bargain Hunters Need to Know Before the Bell on May 4, 2026
    • Berkshire Without Buffett: Is BRK.B the Cheapest Big Bet Nobody Wants Right Now?
    • Klaviyo (KVYO): The Quietly Compounding AI Marketing Machine Wall Street Keeps Sleeping On

    Categories

    • Headlines
    • Business
    • Economy
    • Politics
    • Top News
    • Newsletters

    • Home
    • Disclaimer
    • Contact Us
    • Terms of Service
    • Privacy Policy
    Copyright 2026 © All rights reserved | The Cheap Investor | thecheapinvestor.com
    SITE_OK